UNC Chemical Biology Interface Training Program
北卡罗来纳大学化学生物学界面培训计划
基本信息
- 批准号:10415825
- 负责人:
- 金额:$ 26.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
We propose to establish a Chemistry–Biology Interface (CBI) Training Program that will enable trainees at the
University of North Carolina at Chapel Hill (UNC) to obtain the breadth of scientific training essential for
modern, mechanistically informed chemical biology. This program draws from two historically successful
programs at UNC: the Division of Chemical Biology and Medicinal Chemistry (CBMC) in the UNC Eshelman
School of Pharmacy, and the Biological and Organic Chemistry Divisions in the UNC Department of Chemistry
(College of Arts and Sciences). These two units have a strong and continuing tradition of collaboration,
common coursework, and a shared seminar series. Although UNC has a highly regarded scientific tradition,
there is no chemistry-oriented NIH training program on the UNC campus. The proposed program will bring
together 25 established researchers who encompass the breadth of chemical biology, ranging from analytical
bioanalysis to protein structure/function to medicinal chemistry/drug design. In addition, three promising junior
faculty members will join the program as “mentored mentors”, working closely with senior colleagues as they
continue to establish their programs. The program leaders, one from CBMC and one from the Department of
Chemistry, are accomplished senior faculty with mentoring and administrative experience; they will provide
program guidance with input from an internal steering committee and a distinguished group of external
advisors. Students will be recruited from the two primary units and from a UNC umbrella biological/biomedical
sciences program that has shown remarkable success in recruiting outstanding and diverse graduate students
to the campus. The training program includes (1) common coursework that establishes the basis for research
at the chemistry–biology interface, including responsible conduct of research and rigor/reproducibility training,
(2) biweekly meetings that alternate between a journal club and a smaller discussion group focused on
individual learning and professional development, (3) an program retreat that will be held before the fall
semester, providing orientation and early formal training in rigor and reproducibility, and (4) a trainee-organized
symposium that will become a major annual event at UNC. Work at the chemistry–biology interface has
become increasingly relevant as our understanding of biology has required more molecular insights.
Accordingly, the activities of the proposed program will capitalize on the diverse expertise in CBMC and
Chemistry, and the extensive educational and research resources that are available at this internationally
recognized institution. This program will provide trainees with a superior education from the perspective of
depth and breadth, and develop well-trained PhD scholars at the interface of chemistry and biology who will
play a critical role in the biomedical sciences across academia and industry.
摘要
我们建议建立一个化学-生物学接口(CBI)培训计划,使学员能够在
位于查佩尔山的北卡罗来纳州大学(北卡罗来纳州),以获得科学培训的广度,
现代的、机械的化学生物学。该计划借鉴了两个历史上成功的
化学生物学和药物化学部(CBMC),位于Eshelman
药学院、生物化学系、有机化学系
(艺术与科学学院)。这两个单位有着牢固和持续的合作传统,
共同的课程,和一个共享的研讨会系列。虽然科学家有着高度重视的科学传统,
美国国立卫生研究院的校园里没有以化学为导向的培训项目。该计划将带来
共有25名研究人员,他们涵盖了化学生物学的广度,从分析
生物分析到蛋白质结构/功能到药物化学/药物设计。此外,三位有前途的年轻人
教师将作为“指导导师”加入该计划,与资深同事密切合作,因为他们
继续制定自己的方案。项目负责人,一个来自CBMC,一个来自
化学,是有指导和行政经验的资深教师完成;他们将提供
由内部指导委员会和一个杰出的外部小组提供投入的方案指导
顾问。学生将从两个主要单位和一个生物/生物医学的伞招募
科学项目在招收优秀和多元化的研究生方面取得了显着成功
到校园。培训计划包括(1)建立研究基础的共同课程
在化学-生物学界面,包括负责任地进行研究和严格/再现性培训,
(2)在期刊俱乐部和较小的讨论小组之间交替举行的双周会议,重点是
个人学习和专业发展,(3)秋季前举行的计划务虚会
学期,提供方向和早期正式培训的严谨性和可重复性,和(4)受训者组织
研讨会将成为北卡罗来纳大学的一项重要年度活动。化学生物学界面的研究
变得越来越重要,因为我们对生物学的理解需要更多的分子见解。
因此,拟议计划的活动将利用CBMC的各种专业知识,
化学,以及广泛的教育和研究资源,可在这一国际
认可的机构。该计划将从以下角度为学员提供上级教育:
深度和广度,并在化学和生物学的接口培养训练有素的博士学者,他们将
在学术界和工业界的生物医学科学中发挥关键作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Aube其他文献
Jeffrey Aube的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Aube', 18)}}的其他基金
Small Molecule Therapeutic Discovery for Angelman Syndrome
天使综合症的小分子治疗发现
- 批准号:
10636253 - 财政年份:2023
- 资助金额:
$ 26.4万 - 项目类别:
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
抗结核分枝杆菌磷酸泛酰基转移酶抑制剂的发现
- 批准号:
10450109 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
UNC Chemical Biology Interface Training Program
北卡罗来纳大学化学生物学界面培训计划
- 批准号:
10646465 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
抗结核分枝杆菌磷酸泛酰基转移酶抑制剂的发现
- 批准号:
10653027 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
抗结核分枝杆菌磷酸泛酰基转移酶抑制剂的发现
- 批准号:
10298705 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
UNC Chemical Biology Interface Training Program
北卡罗来纳大学化学生物学界面培训计划
- 批准号:
10089153 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
Kappa 阿片受体的新型探针:化学、药理学和生物学
- 批准号:
9889913 - 财政年份:2016
- 资助金额:
$ 26.4万 - 项目类别:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
Kappa 阿片受体的新型探针:化学、药理学和生物学
- 批准号:
9229013 - 财政年份:2016
- 资助金额:
$ 26.4万 - 项目类别:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
Kappa 阿片受体的新型探针:化学、药理学和生物学
- 批准号:
9113893 - 财政年份:2016
- 资助金额:
$ 26.4万 - 项目类别:
Molecular cancer therapy targeting HuR-ARE interaction
针对 HuR-ARE 相互作用的分子癌症治疗
- 批准号:
9297260 - 财政年份:2015
- 资助金额:
$ 26.4万 - 项目类别:
相似海外基金
CAS-SC: Tuning Hydrocarbon Products from Temperature-Gradient Thermolysis of Polyolefins and the Subsequent Upcycling to Functional Chemicals
CAS-SC:调整聚烯烃温度梯度热解的碳氢化合物产品以及随后升级为功能化学品
- 批准号:
2411680 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
Standard Grant
Building Synthetic Biofilm Consortia for Polyfluorinated Chemicals Biodegradation
建立多氟化学品生物降解合成生物膜联盟
- 批准号:
2343831 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
Standard Grant
Removal of Perfluorinated Chemicals Using New Fluorinated Polymer Sorbents
使用新型氟化聚合物吸附剂去除全氟化化学品
- 批准号:
LP220100036 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
Linkage Projects
The University of Liverpool and Pegasus Chemicals Limited KTP 22_23 R5
利物浦大学和飞马化学有限公司 KTP 22_23 R5
- 批准号:
10063790 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
Knowledge Transfer Partnership
PINK - Provision of Integrated Computational Approaches for Addressing New Markets Goals for the Introduction of Safe-and-Sustainable-by-Design Chemicals and Materials
PINK - 提供综合计算方法来解决引入安全和可持续设计化学品和材料的新市场目标
- 批准号:
10097944 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
EU-Funded
Safe and Sustainable by Design framework for the next generation of Chemicals and Materials
下一代化学品和材料的安全和可持续设计框架
- 批准号:
10110559 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
EU-Funded
Optimising Nature's pharmacies: plant chemicals and pollinator health at the landscape scale
优化大自然的药房:景观尺度上的植物化学物质和传粉媒介健康
- 批准号:
NE/Y000285/1 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
Research Grant
Converting lignin condensed structures into high-value polyaromatic hydrocarbon chemicals by controlled pyrolysis
通过受控热解将木质素缩合结构转化为高价值的多芳烃化学品
- 批准号:
24K17940 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
INSIGHT: Integrated Models for the Development and Assessment of High Impact Chemicals and Materials
洞察力:高影响化学品和材料开发和评估的综合模型
- 批准号:
10097888 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
EU-Funded
ELectrochemical OXidation of cYclic and biogenic substrates for high efficiency production of organic CHEMicals (ELOXYCHEM)
用于高效生产有机化学品的循环和生物底物的电化学氧化 (ELOXYCHEM)
- 批准号:
10110221 - 财政年份:2024
- 资助金额:
$ 26.4万 - 项目类别:
EU-Funded














{{item.name}}会员




